================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15 (d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of Earliest Event Reported): November 21, 2003
Medicis Pharmaceutical Corporation
(Exact Name of Registrant as Specified in Charter)
Delaware 0-18443 52-1574808
(State or Other (Commission File Number) (IRS Employer Identification No.)
Jurisdiction of
Incorporation)
8125 North Hayden Road
Scottsdale, Arizona 85258-2463
(Address of Principal (Zip Code)
Executive Offices)
Registrant's telephone number, including area code: (602) 808-8800
N/A
--------------------------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
================================================================================
Item 7. Financial Statements and Exhibits
(a) Financial Statements of Business Acquired.
Not Applicable.
(b) Pro Forma Financial Information.
Not Applicable.
(c) Exhibits.
99.1 Copy of Press Release, dated November 21, 2003, issued by Medicis
Pharmaceutical Corporation.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this Report to be signed on its behalf by the
undersigned hereunto duly authorized.
MEDICIS PHARMACEUTICAL
CORPORATION
(Registrant)
/s/ Mark A. Prygocki, Sr.
Date: November 21, 2003 ----------------------------------
Name: Mark A. Prygocki, Sr.
Title: Executive Vice President,
Chief Financial Officer,
Corporate Secretary and
Treasurer
EXHIBIT INDEX
EXHIBIT
NUMBER DESCRIPTION
--------------------------------------------------------------------------------
99.1 Copy of Press Release, dated November 21, 2003, issued by
Medicis Pharmaceutical Corporation.